Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nilsson

Showing results (91-100 of 320) with videos related to

Pageof 32
Sort By:
European Journal of Clinical Microbiology|June 1, 1987
Pharmacokinetics of antibiotics in the elderlyB Ljungberg, I Nilsson-Ehle, F Nordbring
Scandinavian Journal of Infectious Diseases|January 1, 1983
Serum and saliva concentrations of sulfamethoxazole and trimethoprim in adults and children: relation between saliva concentrations and in vitro activity against nasopharyngeal pathogensC Kamme, A Melander, N I Nilsson
European Journal of Clinical Pharmacology|January 1, 1989
Effect of urinary pH on the plasma and urinary kinetics of remoxipride in manE Widerlöv, B Termander, M I Nilsson
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1992
A metabolic route of omeprazole involving conjugation with glutathione identified in the ratL Weidolf, K E Karlsson, I Nilsson
FEBS Letters|November 18, 1996
Calnexin can interact with N-linked glycans located close to the endoplasmic reticulum membraneH Andersson, I Nilsson, G von Heijne
Acta Pharmaceutica Suecica|March 1, 1973
Hydrolysis of thiocarbamates and trapping of a reactive intermediate in the hydrolysis of N-monosubstituted arylcarbamates and -thiocarbamatesJ O Bränstad, G Ekberg, I Nilsson
Nature|May 26, 1972
Inducible antibacterial defence system in DrosophilaH G Boman, I Nilsson, B Rasmuson
Leukemia|November 1, 1992
Treatment of minimal residual disease in acute leukemia--focus on immunotherapeutic optionsB Simonsson, B I Nilsson, J M Rowe
Journal of Steroid Biochemistry|June 22, 1990
Phase II clinical study of toremifene in patients with metastatic breast cancer. Preliminary communicationH Modig, S Borgström, I Nilsson, et al.
Leukemia & Lymphoma|November 1, 1993
Treatment of minimal residual disease in myeloid leukemia--the immunotherapeutic options with emphasis on LinomideJ M Rowe, B I Nilsson, B Simonsson
Pageof 32

Showing results (91-100 of 320) with videos related to

Sort By:
Pageof 32
European Journal of Clinical Microbiology|June 1, 1987
Pharmacokinetics of antibiotics in the elderlyB Ljungberg, I Nilsson-Ehle, F Nordbring
Scandinavian Journal of Infectious Diseases|January 1, 1983
Serum and saliva concentrations of sulfamethoxazole and trimethoprim in adults and children: relation between saliva concentrations and in vitro activity against nasopharyngeal pathogensC Kamme, A Melander, N I Nilsson
European Journal of Clinical Pharmacology|January 1, 1989
Effect of urinary pH on the plasma and urinary kinetics of remoxipride in manE Widerlöv, B Termander, M I Nilsson
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1992
A metabolic route of omeprazole involving conjugation with glutathione identified in the ratL Weidolf, K E Karlsson, I Nilsson
FEBS Letters|November 18, 1996
Calnexin can interact with N-linked glycans located close to the endoplasmic reticulum membraneH Andersson, I Nilsson, G von Heijne
Acta Pharmaceutica Suecica|March 1, 1973
Hydrolysis of thiocarbamates and trapping of a reactive intermediate in the hydrolysis of N-monosubstituted arylcarbamates and -thiocarbamatesJ O Bränstad, G Ekberg, I Nilsson
Nature|May 26, 1972
Inducible antibacterial defence system in DrosophilaH G Boman, I Nilsson, B Rasmuson
Leukemia|November 1, 1992
Treatment of minimal residual disease in acute leukemia--focus on immunotherapeutic optionsB Simonsson, B I Nilsson, J M Rowe
Journal of Steroid Biochemistry|June 22, 1990
Phase II clinical study of toremifene in patients with metastatic breast cancer. Preliminary communicationH Modig, S Borgström, I Nilsson, et al.
Leukemia & Lymphoma|November 1, 1993
Treatment of minimal residual disease in myeloid leukemia--the immunotherapeutic options with emphasis on LinomideJ M Rowe, B I Nilsson, B Simonsson
Pageof 32